Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Visualize Index Level and price together to reveal trend strength and timing. This overview helps traders align momentum with price moves.
28,655 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As July looms, the idea that a stock market crash comes can rattle even seasoned investors. This guide shows how a di...
In 2026, the iMGP DBi Managed Futures Strategy ETF (DBMF) is delivering an 11% year-to-date gain against a roughly 5%...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
These software stocks have surged as geopolitical tensions rise, outpacing broader tech gains and signaling a shift i...
Inflation surprised to the upside in April, reviving debate over Fed policy and sending Bitcoin lower as higher yield...
U.S. equities rally into the holiday weekend while fuel costs ease, underscoring a split economy. This report tracks ...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
Comcast announces a spin-off of NBCUniversal after 15 years under one roof, separating the media group into a standal...
Volatility returns to FX markets in 2026. This forex.com review highlights pricing, safety, and platform options trad...
A blockbuster IPO can set the stage for more funding moves. This article explains why spacex raising more cash throug...